JPS56138112A - Suppository containing ascorbic acid or sodium ascorbate - Google Patents

Suppository containing ascorbic acid or sodium ascorbate

Info

Publication number
JPS56138112A
JPS56138112A JP4036880A JP4036880A JPS56138112A JP S56138112 A JPS56138112 A JP S56138112A JP 4036880 A JP4036880 A JP 4036880A JP 4036880 A JP4036880 A JP 4036880A JP S56138112 A JPS56138112 A JP S56138112A
Authority
JP
Japan
Prior art keywords
ascorbic acid
sodium ascorbate
suppository
containing ascorbic
suppository containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4036880A
Other languages
Japanese (ja)
Other versions
JPS631923B2 (en
Inventor
Kunio Sekine
Yoshiki Suzuki
Gentaro Yamashita
Hisao Yamaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP4036880A priority Critical patent/JPS56138112A/en
Priority to DE8181102336T priority patent/DE3171774D1/en
Priority to EP81102336A priority patent/EP0037943B1/en
Priority to US06/249,462 priority patent/US4434159A/en
Publication of JPS56138112A publication Critical patent/JPS56138112A/en
Publication of JPS631923B2 publication Critical patent/JPS631923B2/ja
Granted legal-status Critical Current

Links

Abstract

PURPOSE: A suppository, having improved absorptivity, and containing a medicament and ascorbic acid or sodium salt thereof.
CONSTITUTION: A suppository containing a medicamenet and ascorbic acid and/or sodium ascorbate. The medicament is particularly a peptide hormone, e.g. insulin or calcitonin, enzyme, polysaccharide, e.g. heparin, carcinostatic agent or antibiotic which is, pracically little or only insufficiently, absorbed by the conventional rectal or oral administration. The use of these medicaments as the suppository obtained in the form of a uniform mixture with ascorbic acid and/or sodium ascorbate permits their effective absorption through a rectrum and therefore their administration to a patient even without injection.
COPYRIGHT: (C)1981,JPO&Japio
JP4036880A 1980-03-31 1980-03-31 Suppository containing ascorbic acid or sodium ascorbate Granted JPS56138112A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP4036880A JPS56138112A (en) 1980-03-31 1980-03-31 Suppository containing ascorbic acid or sodium ascorbate
DE8181102336T DE3171774D1 (en) 1980-03-31 1981-03-27 Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
EP81102336A EP0037943B1 (en) 1980-03-31 1981-03-27 Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
US06/249,462 US4434159A (en) 1980-03-31 1981-03-31 Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4036880A JPS56138112A (en) 1980-03-31 1980-03-31 Suppository containing ascorbic acid or sodium ascorbate

Publications (2)

Publication Number Publication Date
JPS56138112A true JPS56138112A (en) 1981-10-28
JPS631923B2 JPS631923B2 (en) 1988-01-14

Family

ID=12578692

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4036880A Granted JPS56138112A (en) 1980-03-31 1980-03-31 Suppository containing ascorbic acid or sodium ascorbate

Country Status (1)

Country Link
JP (1) JPS56138112A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01279839A (en) * 1988-04-30 1989-11-10 Nitto Denko Corp Water-soluble physiologically active protein preparation
WO1991017742A1 (en) * 1988-12-07 1991-11-28 Ss Pharmaceutical Co., Ltd. Sustained release suppository
JP2015120766A (en) * 2009-01-09 2015-07-02 ロート製薬株式会社 Method for inhibiting discoloration of composition for external use containing diphenhydramine or salt thereof and ascorbic acid or salt thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0476156B1 (en) * 1990-04-06 1996-08-07 Eisai Co., Ltd. Solid oral preparation containing catechol compound

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55153712A (en) * 1979-05-18 1980-11-29 Kao Corp Insulin pharmaceutical preparation and its production

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55153712A (en) * 1979-05-18 1980-11-29 Kao Corp Insulin pharmaceutical preparation and its production

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01279839A (en) * 1988-04-30 1989-11-10 Nitto Denko Corp Water-soluble physiologically active protein preparation
WO1991017742A1 (en) * 1988-12-07 1991-11-28 Ss Pharmaceutical Co., Ltd. Sustained release suppository
US5500221A (en) * 1988-12-07 1996-03-19 Ss Pharmaceutical Co., Ltd. Sustained release suppository
JP2015120766A (en) * 2009-01-09 2015-07-02 ロート製薬株式会社 Method for inhibiting discoloration of composition for external use containing diphenhydramine or salt thereof and ascorbic acid or salt thereof

Also Published As

Publication number Publication date
JPS631923B2 (en) 1988-01-14

Similar Documents

Publication Publication Date Title
ES2117642T3 (en) PHARMACEUTICAL PREPARATION CONTAINING N-GLYCOFUROLES AND N-ETILEN GLYCOLS.
JPS56100714A (en) Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane
IL76119A (en) Device for initiating reperfusion treatment when heart attack symptoms are present
ES8201596A1 (en) their preparation and use as medicines.
JPS53113008A (en) Constant rate releasing preparation
JPS56138111A (en) Suppository containing unsaturated fatty acid or salt thereof
JPS56104815A (en) Remedy for peripheral orthostatic hypotension
GR78416B (en)
JPS56138110A (en) Suppository containing citric acid or salt thereof
PT78628A (en) Pharmaceutical composition with reduced toxicity
JPS5551020A (en) Remedy for rheumatism
JPS56138112A (en) Suppository containing ascorbic acid or sodium ascorbate
KR920702225A (en) Pharmaceutical composition
DE2965732D1 (en) Pharmaceutical composition comprising a water soluble salt of amoxycillin and polyvinylpyrrolidone, and a vial containing a unit dose of said composition
JPS57109721A (en) Carcinostatic agent
JPS56138115A (en) Suppository containing acidic amino acid or derivative thereof
JPS5470428A (en) Carcinostatic agent
JPS57144214A (en) Pharmaceutical preparation for rectum medication
JPS56122310A (en) Suppository
JPS53148518A (en) Stabilized prostaglandin e composition and its preparation
JPS5639019A (en) Antiviral agent
JPS5569510A (en) Carcinostatic agent
JPS646214A (en) Remedy for ulcerative colonopathy
KR830008678A (en) Analgesic composition
JPS5341418A (en) Preparation of antibiotic preparations of aminoglycoside series suitable for rectal administration